Linagliptin: an update of its use in patients with type 2 diabetes mellitus.
about
Value of the combined examination of Cys-C and HbA1c for diagnosis of early renal injury in pediatric diabetes.Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Empagliflozin/Linagliptin: A Review in Type 2 Diabetes.Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials.Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke.Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes.
P2860
Linagliptin: an update of its use in patients with type 2 diabetes mellitus.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Linagliptin: an update of its use in patients with type 2 diabetes mellitus.
@en
type
label
Linagliptin: an update of its use in patients with type 2 diabetes mellitus.
@en
prefLabel
Linagliptin: an update of its use in patients with type 2 diabetes mellitus.
@en
P2860
P1433
P1476
Linagliptin: an update of its use in patients with type 2 diabetes mellitus.
@en
P2093
Kate McKeage
P2860
P2888
P304
P356
10.1007/S40265-014-0308-3
P577
2014-10-01T00:00:00Z
P6179
1009218718